$CJMB

Callan JMB Inc. (NASDAQ:CJMB) shares rose about 49.8% to $1.29 after hours after the company said it signed a strategic partnership with Alabama State University to build an integrated pharmaceutical manufacturing ecosystem. Callan will provide logistics and regulatory support and receive 21% of qualifying gross revenue. Management projected annual gross revenues near $500 million, about $105 million for the company. The stock also faces a Nasdaq $1 bid compliance deadline.

Callan JMB Inc. (NASDAQ: CJMB) said it has partnered with Alabama State University to support workforce development and applied research at Atlas Complex in Marion, Alabama. The planned 150-acre pharmaceutical and medical logistics campus aims to support U.S. pharmaceutical onshoring and domestic supply chains, targeting more than $430 million in annual revenue at maturity.

CALLAN JMB INC. (CJMB) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. EX-10.1 2 ex10-1.htm EX-10.1 Exhibit 10.1 Settlement, Waiver and Release Agreement This Settlement, Waiver and Release Agreement (“ Agreement ” or “ Settlement Agreement ”) is made and entered into as of June 5, 2026 (“ Effective Date ”) by and between CALLAN JMB Inc., a Nevada C

Dial Gerald purchased 10,000 shares of CALLAN JMB INC. (CJMB) at $0.76 on 2025-12-30.

Callan JMB Inc. has issued a statement regarding a lawsuit filed against it by Eddie Patent Holdings, LLC in the U.S. District Court for the Northern District of Texas. The company, an integrative logistics provider for the healthcare industry, believes the claims are without merit and intends to respond through legal channels. Callan JMB emphasized that the litigation does not affect its operations or strategic partnerships and remains focused on its long-term goals.

Callan JMB CEO Williams Wayne D. reported two transactions where he purchased company common stock totaling $73,499 at $1.65 per share. These transactions, made indirectly through Health Hero America, LLC, increased Williams' total holdings to 2,262,500 direct shares and significant indirect holdings through various entities. The company also announced recent developments, including an amended insider trading policy, a preliminary agreement for oral drug delivery manufacturing equipment, and an expansion into food sampling logistics.

Expanded the Company's compliance-driven logistics platform into the food sampling industryEntered agreement to install oral drug delivery equipment at Texas facility Established a subsidiary in India and advanced plans for a temperature-controlled pharmaceutical storage and distribution ...

Move leverages the Company's expertise in regulated materials to capture opportunities in sustainable , high-growth consumer markets

Callan JMB Inc. ( NASDAQ:CJMB ) on Monday disclosed the expansion of its reclamation operations into the food sampling industry. Notably, Callan JMB inked a partnership with Keychain, an AI-enabled platform built for the consumer packaged goods sector, to facilitate the expansion.

Sentry Monitoring System allows for remote monitoring of refrigerators, freezers, and clean room temperatures for high-value pharmaceutical products in pharmacies, hospitals, and emergency preparedness facilities ...